Federal Drug Administration panel recommends approval of Cancidas, Merck's investigational antifungal drug.

Source :: The Journal of the Association of Nurses in AIDS Care : JANAC [J Assoc Nurses AIDS Care] 2001 Jul-Aug; Vol. 12 (4), pp. 93-4.
Publication Year :: 2001

Subjects :: Caspofungin
Drug Approval
Echinocandins
Humans
Lipopeptides
United States
AIDS-Related Opportunistic Infections drug therapy
Anti-Bacterial Agents therapeutic use
Antifungal Agents therapeutic use
Mycoses drug therapy
Mycoses virology
Peptides
Peptides, Cyclic

Full Text Access

Tools